| Literature DB >> 32271167 |
Eun-Jin Lee1,2,3, Wei-Chieh Jerry Chiang2,4, Heike Kroeger2,5, Chloe Xiaoke Bi2, Daniel L Chao1, Dorota Skowronska-Krawczyk1, Rebecca R Mastey6, Stephen H Tsang7, Leon Chea8, Kyle Kim2, Scott R Lambert3, Julia Md Grandjean9, Britta Baumann10, Isabelle Audo11,12, Susanne Kohl10, Anthony T Moore13, R Luke Wiseman9, Joseph Carroll6, Jonathan H Lin3,8,14.
Abstract
Achromatopsia (ACHM) is an autosomal recessive disease that results in severe visual loss. Symptoms of ACHM include impaired visual acuity, nystagmus, and photoaversion starting from infancy; furthermore, ACHM is associated with bilateral foveal hypoplasia and absent or severely reduced cone photoreceptor function on electroretinography. Here, we performed genetic sequencing in 3 patients from 2 families with ACHM, identifying and functionally characterizing 2 mutations in the activating transcription factor 6 (ATF6) gene. We identified a homozygous deletion covering exons 8-14 of the ATF6 gene from 2 siblings from the same family. In another patient from a different family, we identified a heterozygous deletion covering exons 2 and 3 of the ATF6 gene found in trans with a previously identified ATF6 c.970C>T (p.Arg324Cys) ACHM disease allele. Recombinant ATF6 proteins bearing these exon deletions showed markedly impaired transcriptional activity by qPCR and RNA-Seq analysis compared with WT-ATF6. Finally, RNAscope revealed that ATF6 and the related ATF6B transcripts were expressed in cones as well as in all retinal layers in normal human retina. Overall, our data identify loss-of-function ATF6 disease alleles that cause human foveal disease.Entities:
Keywords: Cell stress; Ophthalmology
Mesh:
Substances:
Year: 2020 PMID: 32271167 PMCID: PMC7205249 DOI: 10.1172/jci.insight.136041
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708